Pages that link to "Item:Q1681955"
From MaRDI portal
The following pages link to Mathematical modelling of chemotherapy combined with bevacizumab (Q1681955):
Displaying 9 items.
- The study of antitumor efficacy of bevacizumab antiangiogenic therapy using a mathematical model (Q890244) (← links)
- Transient alleviation of tumor hypoxia during first days of antiangiogenic therapy as a result of therapy-induced alterations in nutrient supply and tumor metabolism -- analysis by mathematical modeling (Q1642627) (← links)
- Analysis of anticancer efficiency of combined fractionated radiotherapy and antiangiogenic therapy via mathematical modelling (Q1669287) (← links)
- Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice (Q1715176) (← links)
- Mathematical modeling in scheduling cancer treatment with combination of VEGF inhibitor and chemotherapy drugs (Q1717360) (← links)
- Predictive modeling of neuroblastoma growth dynamics in xenograft model after bevacizumab anti-VEGF therapy (Q1786918) (← links)
- Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors (Q2033852) (← links)
- Investigation of solid tumor progression with account of proliferation/migration dichotomy via Darwinian mathematical model (Q2299259) (← links)
- Mathematical modelling for spatial optimization of irradiation during proton radiotherapy with nanosensitizers (Q6067794) (← links)